The role of inflammation in CNS injury and disease
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
For many years, the central nervous system (CNS) was considered to be ‘immune privileged’, neither susceptible to nor contributing to inflammation. It is now appreciated that the CNS does exhibit features of inflammation, and in response to injury, infection or disease, resident CNS cells generate inflammatory mediators, including proinflammatory cytokines, prostaglandins, free radicals and complement, which in turn induce chemokines and adhesion molecules, recruit immune cells, and activate glial cells. Much of the key evidence demonstrating that inflammation and inflammatory mediators contribute to acute, chronic and psychiatric CNS disorders is summarised in this review. However, inflammatory mediators may have dual roles, with detrimental acute effects but beneficial effects in long‐term repair and recovery, leading to complications in their application as novel therapies. These may be avoided in acute diseases in which treatment administration might be relatively short‐term. Targeting interleukin (IL)‐1 is a promising novel therapy for stroke and traumatic brain injury, the naturally occurring antagonist (IL‐1ra) being well tolerated by rheumatoid arthritis patients. Chronic disorders represent a greater therapeutic challenge, a problem highlighted in Alzheimer's disease (AD); significant data suggested that anti‐inflammatory agents might reduce the probability of developing AD, or slow its progression, but prospective clinical trials of nonsteroidal anti‐inflammatory drugs or cyclooxygenase inhibitors have been disappointing. The complex interplay between inflammatory mediators, ageing, genetic background, and environmental factors may ultimately regulate the outcome of acute CNS injury and progression of chronic neurodegeneration, and be critical for development of effective therapies for CNS diseases. British Journal of Pharmacology (2006) 147, S232–S240. doi:10.1038/sj.bjp.0706400
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As various neurological and psychiatric diseases have been associated with neuroinflammation in some post-mortem studies,183, 184, 185”
From Markers of microglia in post-mortem brain samples from patients with Alzheimer’s disease: a systematic review (2018) · cites this paper as [183]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Stroke is caused by ischaemia, leading to inflammation [900] and to the formation of ROS and other damaging free radicals [901] in the brain”
The cited source says what the claim attributes to it.
In the citing paper
“These processes induce adhesion molecules and, in order, mobilize immune and glial cells in a parallel and synergistic way (94, 126 -128).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [127]
In the citing paper
“Thus, although this is not the focus of the present more physiologically based review, we recognise that many of relationships between ROSs and oxidative stress and overt progressive diseases may be mediated via the inflammatory signalling pathways involved in 'innate immunity' [900,1991-1993].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PLEIOTROPIC EFFECTS OF STATINS
Liao, J. K., & Laufs, U. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095748 · Cited by 1,994
Reactive Astrocytes Protect Tissue and Preserve Function after Spinal Cord Injury
Faulkner, J. R., Herrmann, J. E., Woo, M. J., Tansey, K. E., Doan, N. B., & Sofroniew, M. V. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3547-03.2004 · Cited by 1,598 · cited 1×
“…for repair and recovery, but in fact this increases neuronal loss from the injury site and inhibits repair of the BBB and axonal remyelination (Faulkner et al., 2004), partly because astrocytes produce neurotrophic factors such as nerve growth factor and brain-derived growth factor that are…”
BackgroundMcGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367 · cited 1×
“Although other epidemiological studies also suggest a beneficial role for antiinflammatory agents in AD (McGeer et al., 1996), the general view from prospective trials of nonsteroidal inflammatory drugs (NSAIDs) is that they are disappointingly variable.”
BackgroundTNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study
The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group (1999) · Neurology · doi:10.1212/wnl.53.3.457 · Cited by 1,017
Interleukin 1 in the brain: biology, pathology and therapeutic target
Rothwell, N. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01661-1 · Cited by 671 · cited 3×
“IL-1 was discovered as an important endogenous pyrogen, and is now recognised as the ‘prototypic inflammatory cytokine’ (reviewed by Rothwell & Luheshi, 2000).”
BackgroundInfluentialSelf-citationPerry, V. H. (2004) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2004.01.004 · Cited by 560 · cited 2×
“…metalloproteinase and iNOS activities, and breakdown of the BBB. Complications of its use however include inhibition of remyelination in MS models, and observations that microglial activation may be associated with anti-inflammatory cytokine expression rather than proinflammatory (Perry, 2004).”
BackgroundInflammation and the Degenerative Diseases of Aging
McGEER, P. L., & McGEER, E. G. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.007 · Cited by 518 · cited 1×
“The complement cascade is activated, and mRNAs for complement proteins are upregulated in PD (and AD) to a greater extent than in peripheral inflammatory diseases such as rheumatoid arthritis (reviewed by McGeer & McGeer, 2004).”
BackgroundScherbel, U., Raghupathi, R., Nakamura, M., Saatman, K. E., Trojanowski, J. Q., Neugebauer, E., Marino, M. W., & McIntosh, T. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8721 · Cited by 415 · cited 1×
“…injury, the TNFa knockout mice show less behavioural impairment than the wild-type controls, but while the wild-type mice recovered in the weeks following injury, the knockout mice did not, remaining significantly impaired both in terms of histological damage and behaviour (Scherbel et al., 1999).”
BackgroundNew Insights into the Biology of the Acute Phase Response
Suffredini, A. F., Fantuzzi, G., Badolato, R., Oppenheim, J. J., & O'Grady, N. P. (1999) · Journal of Clinical Immunology · doi:10.1023/a:1020563913045 · Cited by 391 · cited 1×
“This represents another host defence mechanism which can limit proliferation of invading pathogens (Suffredini et al., 1999).”
BackgroundVezzani, A., Moneta, D., Richichi, C., Aliprandi, M., Burrows, S. J., Ravizza, T., Perego, C., & De Simoni, M. G. (2002) · Epilepsia · doi:10.1046/j.1528-1157.43.s.5.14.x · Cited by 386 · cited 1×
“Exogenous IL-1b enhances chemically induced seizures in rats and IL-1ra inhibits motor seizures and delays their onset (see Vezzani et al., 2002).”
Background
Cited by
Items 501–600 of 1,000
Rapid Analytical Methods for On-Site Triage for Traumatic Brain Injury
North, S. H., Shriver‐Lake, L. C., Taitt, C. R., & Ligler, F. S. (2012) · Annual Review of Analytical Chemistry · doi:10.1146/annurev-anchem-062011-143105 · Cited by 47
Choy, F. C., Klarić, T., Leong, W. K., Koblar, S. A., & Lewis, M. D. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15606146 · Cited by 47
“Numerous studies have reported the crucial role of cytokines such as IL-6 and TNF-a, which are markedly increased in the acute phase after stroke onset, in the initiation and promotion of inflammation and the development of secondary brain injury.(22) We therefore investigated whether ablation of Npas4 also influences…”
BackgroundMalekzadeh, A., de Groot, V., Beckerman, H., van Oosten, B. W., Blankenstein, M. A., & Teunissen, C. E. (2012) · Methods · doi:10.1016/j.ymeth.2012.03.017 · Cited by 46
Grzesiak, J., Marycz, K., Szarek, D., Bednarz, P., & Laska, J. (2015) · Materials Science and Engineering C · doi:10.1016/j.msec.2015.03.050 · Cited by 46
Evaluation of IL-1β levels in epilepsy and traumatic brain injury in dogs
Kostic, D., Carlson, R., Henke, D., Röhn, K., & Tipold, A. (2019) · BMC Neuroscience · doi:10.1186/s12868-019-0509-5 · Cited by 46
Redox and Immune Signaling in Schizophrenia: New Therapeutic Potential
Dwir, D., Khadimallah, I., Xin, L., Rahman, M., Du, F., Öngür, D., & Kim, Q. (2023) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyad012 · Cited by 46
“This regulation is extremely important in the brain because an imbalance leads to chronic neuroinflammation through astrocytic activation, peripheral immune cell recruitment, neuronal injury, and blood–brain barrier disruption (Lucas et al., 2009).”
BackgroundNew Prognostic Biomarkers in Patients With Traumatic Brain Injury
Lorente, L. (2015) · Archives of Trauma Research · doi:10.5812/atr.30165 · Cited by 46
“Secondary injury occurs over a period of hours or days following the initial trauma, and results from the activation of different pathways such as inflammation, coagulation, oxidation, and apoptosis (2-10).”
BackgroundCytochrome P4504f, a potential therapeutic target limiting neuroinflammation
Sehgal, N., Agarwal, V., Valli, R. K., Joshi, S. D., Antonovič, L., Strobel, H. W., & Ravindranath, V. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.03.025 · Cited by 46
Berkowitz, S. H., Chapman, J., Dori, A., Gofrit, S. G., Maggio, N., & Stein, E. S. (2021) · Biomedicines · doi:10.3390/biomedicines9121950 · Cited by 45
“the CNS and PNS, there is an increase in proinflammatory mediators that modulate nerve function [11,12].”
BackgroundPioglitazone Therapy and Fractures: Systematic Review and Meta- Analysis
Pavlova, V., Filipova, E., Uzunova, K., Kalinov, K., & Vekov, T. (2021) · Endocrine, Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530318666180423121833 · Cited by 43
The effect of central administration of alpha‐pinene on capsaicin‐induced dental pulp nociception
Rahbar, I., Abbasnejad, M., Haghani, J., Raoof, M., Kooshki, R., & Esmaeili‐Mahani, S. (2018) · International Endodontic Journal · doi:10.1111/iej.13006 · Cited by 45
Haj‐Mirzaian, A., Ramezanzadeh, K., Tafazolimoghadam, A., Kazemi, K., Nikbakhsh, R., Nikbakhsh, R., Amini-Khoei, H., Afshari, K., Haddadi, N., Shakiba, S., et al. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172446 · Cited by 45
Mesenchymal Stem Cell-Mediated Mitochondrial Transfer: a Therapeutic Approach for Ischemic Stroke
Lü, M., Guo, J., Wu, B., Zhou, Y., Wu, M., Farzaneh, M., & Khoshnam, S. E. (2020) · Translational Stroke Research · doi:10.1007/s12975-020-00853-6 · Cited by 46
Zhang, Y., Lei, Y., Yao, X., Yi, J., & Feng, G. (2021) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13956 · Cited by 45
“…ultimately aggravating neurological injury and dysfunction (Corrigan et al., 2016; Guadagno et al., 2015; Hankey, 2017; Kettenmann et al., 2011; Lucas et al., 2006; Neher et al., 2013; Tremblay et al., 2011; Wang, Mao, et al., 2020; Wang, Higashikawa, et al., 2020; Wu et al., 2020; Xu et al.,…”
BackgroundYe, Y., Xing, H., & Chen, X. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0138-y · Cited by 45
“Inflammation is related to many diseases such as cancer, diabetes, and cardiovascular diseases, etc. (Lucas et al. 2006); it is the body’s immediate response to the damage of its tissues and cells by pathogens, noxious substances, or physical injury (Weiss 2008).”
BackgroundBhardwaj, M., & Kumar, A. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2016.07.005 · Cited by 45
Kulkarni, A., Ganesan, P., & O’Donnell, L. A. (2016) · Clinical Medicine Insights Pathology · doi:10.4137/cpath.s40497 · Cited by 45
Nrf2 as a Potential Therapeutic Target for Traumatic Brain Injury
Muneer, P. M. A. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2204081 · Cited by 44
Kipp, M., Berger, K., Clarner, T., Dang, J., & Beyer, C. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02163.x · Cited by 42
Bonaccini, L., Karioti, A., Bergonzi, M. C., & Bilia, A. R. (2015) · Planta Medica · doi:10.1055/s-0035-1546196 · Cited by 44
“A wealth of potential inflammatory targets for intervention have been proposed, including microglial activation and leukocyte extravasation via adhesion molecules or MMPs, NO and iNOS, COX-2, and cytokines such as IL-1 and TNF α [64].”
BackgroundBiomarkers in traumatic brain injury: a review
Toman, E., Harrisson, S., & Belli, A. (2015) · Journal of the Royal Army Medical Corps · doi:10.1136/jramc-2015-000517 · Cited by 44
Gandhi, A. S., Budac, D. P., Khayrullina, T., Staal, R. G. W., & Chandrasena, G. (2017) · Future Science OA · doi:10.4155/fsoa-2016-0067 · Cited by 44
Sharma, R., Rooke, J., Kolmogorova, D., Melanson, B., Mallet, J., Matar, C., Schwarz, J., & Ismail, N. (2018) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2018.07.012 · Cited by 37
Welcome, M. O. (2020) · PharmaNutrition · doi:10.1016/j.phanu.2020.100176 · Cited by 44
Emerging Neurological and Psychobiological Aspects of COVID-19 Infection
Tancheva, L. P., Petralia, M. C., Miteva, S., Dragomanova, S., Solak, A., Kalfin, R. E., Lazarova, M. I., Yarkov, D., Ciurleo, R., Cavalli, E., et al. (2020) · Brain Sciences · doi:10.3390/brainsci10110852 · Cited by 44
“Indirect mechanisms of neurotoxici y may be mediated by immunocompetent and i fla mat ry cells responsible for ex cerbating the pro-inflammato y status of the CNS [73].”
BackgroundInflammation in the pathogenesis of ischemic stroke
Pei, J., You, X., & Fu, Q. (2015) · Frontiers in bioscience · doi:10.2741/4336 · Cited by 44
Quintana, A., Molinero, A., Borup, R., Nielsen, F. C., Campbell, I. L., Penkowa, M., & Hidalgo, J. (2007) · Developmental Neurobiology · doi:10.1002/dneu.20584 · Cited by 44
“…and the infiltration and activation of inflammatory leukocytes and microglia, which generate proinflammatory factors, tissue digesting enzymes, adhesion/costimulatory molecules, complement, arachidonic acid metabolites, and reactive oxygen species (Lucas et al., 2006; Seifert et al., 2006).”
Fang, Y., Yan, J., Li, C., Zhou, X. Q., Yao, L., Pang, T., Yan, M., Zhang, L., Mao, L., & Liao, H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.678326 · Cited by 44
“In many CNS disorders, such as multiple sclerosis (MS) and Alzheimer disease (AD), chronic inflammation is one of the main pathologic features (30).”
BackgroundZheng, H., Guo, X., Kang, S., Li, Z., Tian, T., Li, J., Wang, F., Yu, P., Chang, S., & Chang, Y. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05688-1 · Cited by 43
“Ischemic stroke can cause serious neurological damage, mainly through oxidative stress [46], inflammation [23], and excitatory neurotoxicity [19, 24].”
BackgroundRecent molecular approaches to understanding astrocyte function in vivo
Davila, D., Thibault, K., Fiacco, T. A., & Agulhon, C. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00272 · Cited by 38
“Several examples have been provided in this review, including generation of conditional and inducible genetically engineered mouse lines for selective expression or removal of specific astrocyte proteins, as well as viral- or IUE-mediated gene delivery techniques for the study of astrocyte function.”
BackgroundMethodInfluentialRashno, M., Ghaderi, S., Nesari, A., Khorsandi, L., Farbood, Y., & Sarkaki, A. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05482-3 · Cited by 43
“Closed head weight-drop model was induced according to the method described by Marmarou et al. (Marmarou et al. 1994) with minor modifications, using a TBI device made in the Physiology Research Center of AJUMS (Ahvaz, Iran).”
RetractedMANF is neuroprotective against ethanol-induced neurodegeneration through ameliorating ER stress
Wang, Y., Wen, W., Li, H., Clementino, M., Xu, H., Xu, M., Ma, M., Frank, J. A., & Luo, J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105216 · Cited by 43
Hellewell, S. C., & Morganti-Kossmann, M. C. (2012) · Mediators of Inflammation · doi:10.1155/2012/356494 · Cited by 43
“Increased BBB permeability facilitates the infiltration of peripheral immune cells and activation of resident immune cells, which release chemokines and cytokines and thus perpetuate the inflammatory response in the injured brain, with the end result of cellular dysfunction and death [44–46].”
BackgroundSpulber, S. D., & Schultzberg, M. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.10.015 · Cited by 43
Chang, R. C., Chiu, K., Ho, J. Y. S., & So, K. (2009) · Cellular and Molecular Immunology · doi:10.1038/cmi.2009.42 · Cited by 43
Inflammatory Mediators in Epilepsy
Pedré, L. L., Chacón, L. M. M., Orozco-Suárez, S. A., Fuentes, N. P., Díaz, B. E., Sánchez, T. S., Maeso, I. G., & Rocha, L. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319380009 · Cited by 43
Impact of genetic factors on outcome from brain injury
Wilson, M. H., & Montgomery, H. (2007) · British Journal of Anaesthesia · doi:10.1093/bja/aem142 · Cited by 43
Gabbi, P., Ribeiro, L. R., Martins, G. J., Cardoso, A. S., Haupental, F., Rodrigues, F. S., Machado, A. K., Brum, J. S., Duarte, M. M. F., Schetinger, M. R. C., et al. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw121 · Cited by 42
Gray, E., Ginty, M., Kemp, K. C., Scolding, N. J., & Wilkins, A. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07637.x · Cited by 42
“It is possible that these effects may be partly dependent on inhibition of nuclear factor kappaB-dependent proinflammatory cytokines released in the injured brain (Stahel et al., 1998; Shohami et al., 1999; Felderhoff-Mueser et al., 2005; Lucas et al., 2006; Gopcevic et al., 2007).”
BackgroundGenetically Modified Mesenchymal Stem Cells: The Next Generation of Stem Cell-Based Therapy for TBI
Shahror, R. A., Wu, C.-C., Chiang, Y. H., & Chen, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114051 · Cited by 42
Hempel, C., Nörenberg, W., Sobottka, H., Urban, N. D., Nicke, A., Fischer, W., & Schaefer, M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.027 · Cited by 42
Correction: Oxidative Burst of Circulating Neutrophils Following Traumatic Brain Injury in Human
Liao, Y., Liu, P., Guo, F., Zhang, Z., & Zhang, Z. (2013) · PLoS ONE · doi:10.1371/annotation/73ce45d3-4478-4c06-a4d2-3274b6222bae · Cited by 42
Bile acids attenuate PKM2 pathway activation in proinflammatory microglia
Romero-Ramírez, L., García-Rama, C., Wu, S., & Mey, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-05408-3 · Cited by 41
“(3) The effects of bile acids in vitro could be mimicked inhibiting NFĸB signaling.”
BackgroundToll-like receptor 4 signaling: A common biological mechanism of regimen-related toxicities
Wardill, H. R., Sebille, Y. Z. A. V., Mander, K. A., Gibson, R. J., Logan, R. M., Bowen, J. M., & Sonis, S. T. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2014.11.005 · Cited by 41
“It has been postulated that TLR4-mediated NFjB signaling plays a critical role in the development of neuroinflammation, leading to the secretion of proinflammatory cytokines, chemokines and enzymes such as cyclooxygenase (COX)-2 and matrix metalloproteinases (MMPs) [54,55].”
BackgroundSelf-citationNosocomial Infections in the Neurointensive Care Unit
Busl, K. M. (2017) · Neurologic Clinics · doi:10.1016/j.ncl.2017.06.012 · Cited by 42
Three-tissue microphysiological system for studying inflammatory responses in gut-liver Axis
Jeon, J., Choi, N., Lee, S. H., & Sung, J. H. (2020) · Biomedical Microdevices · doi:10.1007/s10544-020-00519-y · Cited by 41
Neuroimmune crosstalk and evolving pharmacotherapies in neurodegenerative diseases
Baidya, F., Bohra, M., Datta, A., Sarmah, D., Shah, B., Jagtap, P., Raut, S., Sarkar, A., Singh, U., Kalia, K., et al. (2021) · Immunology · doi:10.1111/imm.13264 · Cited by 38
Otsuka, T., Imura, T., Nakagawa, K., Shrestha, L., Takahashi, S., Kawahara, Y., Sueda, T., Kurisu, K., & Yuge, L. (2018) · Stem Cells and Development · doi:10.1089/scd.2017.0299 · Cited by 41
Cantarella, G., Pignataro, G., Benedetto, G. D., Anzilotti, S., Vinciguerra, A., Cuomo, O., Renzo, G. F. D., Parenti, C., Annunziato, L., & Bernardini, R. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.286 · Cited by 41
Brain Remodelling following Endothelin-1 Induced Stroke in Conscious Rats
Abeysinghe, H. C. S., Bokhari, L., Dusting, G. J., & Roulston, C. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097007 · Cited by 41
“Microglia may also exert neuroprotection by producing neurotrophic molecules such as brain-derived neurotrophic factor (BDNF), insulin-like growth factor 1 (IGF-1), and several other growth factors [66].”
BackgroundMartínez‐Revelles, S., Jiménez‐Altayó, F., Caracuel, L., Pérez-Asensio, F. J., Planas, A. M., & Vila, E. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.134619 · Cited by 41
“It is known that cytokines are rapidly up-regulated in response to injury, infection and inflammation (Lucas et al., 2006).”
BackgroundSong, J., Li, N., Xia, Y., Gao, Z., Zou, S.-F., Kong, L., Yao, Y.-J., Jiao, Y.-N., Yan, Y.-H., Li, S.-H., et al. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00182 · Cited by 41
Chen, S.-Y., Lin, M.-C., Tsai, J.-S., He, P.-L., Luo, W.-T., Herschman, H., & Li, H.-J. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.18-0284 · Cited by 38
Bushell, T. J. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.129577 · Cited by 41
“Indeed, the up-regulation of inflammatory cytokines, for example TNF-α, TNF-β, IL-1β and IL-6, are observed in acute CNS conditions such as brain trauma, as well as in chronic CNS diseases states, such as Alzheimer’s disease, Parkinson’s disease and multiple sclerosis (Campbell, 2004; Lucas et al. 2006).”
BackgroundSmith, E. R., Nilforooshan, R., Weaving, G., & Tabet, N. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-101872 · Cited by 40
“even augment amyloid- (A ) plaque deposition and neurofibrillary tangle (NFT) formation—the classical histopathological hallmarks of AD [2, 3].”
BackgroundRole of the transcription factor NRF2 in maintaining the integrity of the Blood-Brain Barrier
Cazalla, E., Cuadrado, A., & García‐Yagüe, Á. J. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00599-5 · Cited by 41
“Immediately after a brain injury, a huge quantity of inflammatory cytokines such as IL-1β, IL-6, TNF-α and TGF-β are released into the blood circulation which further exacerbates the trauma condition of the brain with oxidative stress [140, 141].”
Minocycline mitigates isoflurane-induced cognitive impairment in aged rats
Li, S.-Y., Xia, L., Zhao, Y., Liu, Y., Chen, Y.-L., Wang, J.-T., & Luo, A. (2012) · Brain Research · doi:10.1016/j.brainres.2012.12.025 · Cited by 40
Anti-inflammatory properties of quebecol and its derivatives
Cardinal, S., Azelmat, J., Grenier, D., & Voyer, N. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.11.096 · Cited by 40
Role of B cells and the aging brain in stroke recovery and treatment
Engler-Chiurazzi, E. B., Monaghan, K. L., Wan, E. C. K., & Ren, X. S. (2020) · GeroScience · doi:10.1007/s11357-020-00242-9 · Cited by 40
“Indeed, chronic inflammation mediated by the innate immune response is implicated in a variety of neurodegenerative diseases and new evidence suggests that anti-inflammatory agents may represent a promising therapeutic avenue for their treatment (Lucas et al. 2006).”
BackgroundVentriculitis: Infection or Inflammation
Ramanan, M., Shorr, A. F., & Lipman, J. (2021) · Antibiotics · doi:10.3390/antibiotics10101246 · Cited by 40
Sun, D., Xu, J., Zhang, W., Song, C., Gao, C., He, Y., & Shang, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1012459 · Cited by 40
“A large amount of pro-inflammation factors result in neuronal cell death (68).”
BackgroundInfluence of Inflammation on Poststroke Plasticity
Liguz‐Lecznar, M., & Kossut, M. M. (2013) · Neural Plasticity · doi:10.1155/2013/258582 · Cited by 40
“In the brain parenchyma, IL-6 activates gliosis and leukocyte activation [70].”
InfluentialTropisetron ameliorates ischemic brain injury in an embolic model of stroke
Rahimian, R., Daneshmand, A., Mehr, S. E., Barzegar‐Fallah, A., Mohammadi-Rick, S., Fakhfouri, G., Shabanzadeh, A. P., & Dehpour, A. R. (2011) · Brain Research · doi:10.1016/j.brainres.2011.03.053 · Cited by 40
Which Comorbidities and Complications Predict Ischemic Stroke Recovery and Length of Stay?
Mohamed, W., Bhattacharya, P. D., Shankar, L., Chaturvedi, S., & Madhavan, R. (2015) · The Neurologist · doi:10.1097/nrl.0000000000000040 · Cited by 40
“This includes injury to the vulnerable brain tissue in the ischemic penumbra due to a rise in the core temperature from systemic inflammation as a result of infections.(15,16) The American Stroke Association has recommended screening patients for evidence of urinary infections if they develop a fever in the poststroke…”
BackgroundZussy, C., Loustalot, F., Junyent, F., Gardoni, F., Bories, C., Valero, J., Desarménien, M. G., Bernex, F., Henaff, D., Bayó-Puxan, N., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0132-16.2016 · Cited by 41
“In combination with genetic triggers, a compounding and unifying factor in the physiopathology of many brain diseases is a proinflammatory environment that perturbs synapse homeostasis and adult neurogenesis (Lucas et al., 2006).”
BackgroundPolymorphisms of pro-inflammatory genes and Alzheimer's disease risk: A pharmacogenomic approach
Candore, G., Balistreri, C. R., Grimaldi, M. P., Listì, F., Vasto, S., Chiappelli, M., Licastro, F., Colonna‐Romano, G., Lio, D., & Caruso, C. (2006) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.11.013 · Cited by 40
Muneer, P. M. A., Bhowmick, S., & Briski, N. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0812-z · Cited by 40
“For instance, shortly after brain injury, there is mass production of IL-1β, which exacerbates damage to the brain from oxidative stress that can delay recovery [59, 60].”
Lin, C.-C., Chiang, T.-H., Sun, Y., & Lin, M.-S. (2019) · Nutrients · doi:10.3390/nu11030700 · Cited by 39
“A variety of molecular pathways underlie the pathologies of aging in the CNS and aging-related diseases such as chronic inflammation [14,35], mitochondrial dysfunction [5,6], and dysregulation of apoptosis [36].”
BackgroundFarrerol alleviates collagenase‐induced tendinopathy by inhibiting ferroptosis in rats
Wu, Y., Qian, J., Li, K., Li, W., Yin, W., & Jiang, H. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17388 · Cited by 39
Effects of IFN-γ, TNF-α, IL-10 and TGF-β on Neospora caninum infection in rat glial cells
de Jesus, E. E. V., Pinheiro, A. M., Santos, A. B. S., Freire, S. M., Tardy, M., El-Bachá, R. D. S., Costa, S. L., & Costa, M. F. D. (2012) · Experimental Parasitology · doi:10.1016/j.exppara.2012.11.016 · Cited by 39
Expression of chemokine-like factor 1 after focal cerebral ischemia in the rat
Kong, L., Hu, J., Zhang, W., Yuan, Y., Ma, K., Han, N., & Chen, N. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.09.031 · Cited by 39
Yanguas‐Casás, N., Barreda-Manso, M. A., Pérez-Rial, S., Nieto‐Sampedro, M., & Romero‐Ramírez, L. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0142-6 · Cited by 40
“luciferase [3] under the control of 12 repeats of Smad-binding element (SBE).”
Effect of minocycline on pentylenetetrazol-induced chemical kindled seizures in mice
Ahmadirad, N., Shojaei, A., Javan, M., Pourgholami, M. H., & Mirnajafi‐Zadeh, J. (2013) · Neurological Sciences · doi:10.1007/s10072-013-1552-0 · Cited by 38
Karlsson, C., Schank, J. R., Rehman, F., Stojakovic, A., Björk, K., Barbier, E., Solomon, M. G., Tapocik, J. D., Engblom, D., Thorsell, A., et al. (2016) · Addiction Biology · doi:10.1111/adb.12416 · Cited by 38
Synthesis and Anti-Inflammatory Activity Evaluation of Some Benzimidazole Derivatives
Moharana, A. K., Dash, R. N., Mahanandia, N. C., & Subudhi, B. B. (2022) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-022-02755-3 · Cited by 38
Cell death in the injured brain: Roles of metallothioneins
Pedersen, M. Ø., Larsen, A., Stoltenberg, M., & Penkowa, M. (2008) · Progress in Histochemistry and Cytochemistry · doi:10.1016/j.proghi.2008.10.002 · Cited by 38
Klegeris, A., Madeira, J., & Schindler, S. M. (2015) · Neural Regeneration Research · doi:10.4103/1673-5374.153686 · Cited by 38
“Neuroinflammation contributes to the pathogenesis of a wide range of neurodegenerative disorders especially during their early stages before irreversible changes, such as plaque formation, have occured (Lucas et al., 2006).”
BackgroundDisruption of neurogenesis by hypothalamic inflammation in obesity or aging
Purkayastha, S., & Cai, D. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9279-z · Cited by 38
Wu, Z., Cai, Z., Shi, H., Huang, X., Cai, M., Yuan, K., Huang, P., Shi, G., Yan, T., & Li, Z. (2022) · Aging · doi:10.18632/aging.204030 · Cited by 37
Su, W., Ju, J., Gu, M., Wang, X., Liu, S., Yu, J., & Mu, D.-L. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02786-x · Cited by 37
“IL-1β and IL-6 have been shown to enhance blood–brain barrier permeability through cytokines-induced tight junction degradation, particularly ZO-1 and claudin-5 [64–66].”
Age-related impact of social isolation in mice: Young vs middle-aged
Magalhães, D. M., Mampay, M., Sebastião, A. M., Sheridan, G. K., & Valente, C. A. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105678 · Cited by 37
“…astrocytes (cid:0) reactive gliosis (cid:0) with overproduction of inflammatory mediators, such as cytokines, chemokines, reactive oxygen species and secondary messengers (Lucas et al., 2006), which contribute to modulation of the immune response (Ransohoff and Perry 2009; Hinwood et al., 2012).”
BackgroundJeong, J. Y., Chung, Y. C., & Jin, B. K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081927 · Cited by 37
YKL-40 and neuron-specific enolase in neurodegeneration and neuroinflammation
Dichev, V., Kazakova, M., & Sarafian, V. S. (2020) · Reviews in the Neurosciences · doi:10.1515/revneuro-2019-0100 · Cited by 37
Melatonin: a promising neuroprotective agent for cerebral ischemia-reperfusion injury
Tozihi, M., Shademan, B., Yousefi, H., Avcı, Ç. B., Nourazarian, A., & Dehghan, G. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1227513 · Cited by 37
“It is recognized as a significant contributor to the deterioration and impairment of cellular processes within an organism (Lucas et al., 2006).”
Hossain, M. M., Sonsalla, P. K., & Richardson, J. R. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.09.011 · Cited by 37
“, 2010), which have been implicated as significant contributors to neurodegeneration (Block and Hong, 2007; Lucas et al., 2006).”
BackgroundOkuyama, S., Miyoshi, K., Tsumura, Y., Amakura, Y., Yoshimura, M., Yoshida, T., Nakajima, M., & Furukawa, Y. (2015) · Brain Sciences · doi:10.3390/brainsci5020118 · Cited by 37
“The over-activation of microglia and subsequently excessive production of inflammatory cytokines are known to be neurotoxic [26]; therefore, we then valuated the level of mRNA expression of inflammatory factors (TNF-α, IL-1β, iNOS and COX-2) by RT-PCR.”
BackgroundLeite, M. R., Cechella, J. L., Mantovani, A. C., Duarte, M. M. M. F., Nogueira, C. W., & Zeni, G. R. (2014) · Cytokine · doi:10.1016/j.cyto.2014.09.006 · Cited by 37
Lorente, L., Martin, M. M. I. D. O., López, P., Ramos, L., Blanquer, J., Cáceres, J. J., Solé‐Violán, J., Solera, J. A., Cabrera, J., Argüeso, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094370 · Cited by 37
“During the secondary injury there is an increase in the permeability of BBB and consequently appears brain edema [2–5].”
BackgroundQian, Y., Guan, T., Tang, X., Huang, L., Huang, M., Li, Y., Sun, H., Yu, R. M., & Zhang, F. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.10.095 · Cited by 37
“Taken together, these data suggest that maslinic acid treatment may protect the centralnervous system(CNS)against inflammation-induced injury, which contributes to acute and chronic CNS disorders (Lucas et al., 2006).”
BackgroundGlia-neuronal interactions in ictogenesis and epileptogenesis: role of inflammatory mediators
Vezzani, A., Auvin, S., Ravizza, T., & Aronica, E. (2012) · Europe PMC (PubMed Central) · Cited by 36
Pretorius, L., Kell, D. B., & Pretorius, E. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00851 · Cited by 36
“While neuro-inflammation is a part of the normal aging brain, and is a hallmark of acute injury (Lucas et al., 2006) and also of infection (McColl et al.”
BackgroundWarnock, A., Toomey, L. M., Wright, A. J., Fisher, K., Won, Y., Anyaegbu, C. C., & Fitzgerald, M. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2019.6890 · Cited by 36
Malekahmadi, M., Moghaddam, O. M., Islam, S. M. S., Tanha, K., Nematy, M., Pahlavani, N., Firouzi, S., Zali, M. R., & Norouzy, A. (2020) · Trials · doi:10.1186/s13063-019-4008-x · Cited by 36
Dabouz, R., Cheng, C. W. H., Abram, P., Omri, S., Cagnone, G., Sawmy, K. V., Joyal, J., Desjarlais, M., Olson, D. M., Weil, A. G., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02032-8 · Cited by 36
Yao, Z., Liu, N., Zhu, X., Wang, L., Zhao, Y., Liu, Q., Gao, C., & Li, J. (2020) · Aging · doi:10.18632/aging.202349 · Cited by 36
Taraxasterol Inhibits LPS-Induced Inflammatory Response in BV2 Microglia Cells by Activating LXRα
Liu, B., He, Z., Wang, J., Xin, Z., Wang, J., Li, F., & Fu, Y. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00278 · Cited by 36
“These inflammatory cytokines initiate and amplify the inflammatory response and lead to development of neurodegenerative diseases (Lucas et al., 2006).”
BackgroundCentral and peripheral neuroimmune responses: hyporesponsiveness during pregnancy
Spencer, S. J., Mouihate, A., Galic, M. A., & Pittman, Q. J. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2007.144006 · Cited by 31
“Thus, IL-1ra reduces ischaemic damage (Lucas et al. 2006), as does administration of iNOS inhibitors (Iadecola et al.”
BackgroundZhang, Z., Ma, W., Wang, L., Gong, H., Tian, Y., Zhang, J., Liu, J., Lu, H., Chen, X., & Liu, Y. (2015) · Stem Cells and Development · doi:10.1089/scd.2015.0067 · Cited by 35
Unzeta, M., Hernández‐Guillamón, M., Sun, P., & Solé, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073365 · Cited by 35
Baradaran, Z., Vakilian, A., Zare, M., Hashemzehi, M., Hosseini, M., Dinpanah, H., & Beheshti, F. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113399 · Cited by 35
Metadata
- Authors
- Lucas, S., Rothwell, N. J., & Gibson, R. M.
- Affiliations
- University of Manchester (GB)
- HSE Science and Research Centre (GB)
- Corresponding author
- Rothwell, Nancy J
- ORCID
- Rothwell, Nancy J
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2006-01
- Volume
- 147
- Issue
- S1
- Pages
- S232-40
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC1760754
- OpenAlex
- W1594425991
- Cited by
- 1,272
- References
- 41
- Citations by year
- 2026: 12 · 2025: 37 · 2024: 32 · 2023: 57 · 2022: 65 · 2021: 69 · 2020: 62 · 2019: 80 · 2018: 67 · 2017: 67 · 2016: 60 · 2015: 89 · 2014: 77 · 2013: 79 · 2012: 62
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Keywords
- neuroinflammation, central nervous system injury, immune privilege, inflammatory cytokines, prostaglandins, free radicals, complement system, chemokines, glial activation, interleukin-1, interleukin-1 receptor antagonist, stroke, traumatic brain injury, Alzheimer's disease, anti-inflammatory therapy, neurodegeneration, aging
- MeSH terms
- Acute Disease, Animals, Brain, Central Nervous System Diseases, Chronic Disease, Craniocerebral Trauma, Humans, Inflammation, Inflammation Mediators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.